ALLOGRAFT DYSFUNCTION Clinical Trials

3 clinical trials for ALLOGRAFT DYSFUNCTION across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• BELUMOSUDIL TO BLOCK CLAD IN HIGH RISK LUNG TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, PHASE 3 STUDY, FOLLOWED BY OPEN-LABEL EXTENSIONS, TO EVALUATE THE EFFICACY OF ORAL BELUMOSUDIL IN ADULT PARTICIPANTS WITH CHRONIC LUNG ALLOGRAFT DYSFUNCTION (CLAD) FOLLOWING BILATERAL LUNG TRANSPLANTATION — RECRUITING · PHASE3
• A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLINDED, PLACEBO CONTROLLED STUDY TO ASSESS THE SAFETY, EFFICACY, AND TOLERABILITY OF ARGX-117 IN IMPROVING ALLOGRAFT FUNCTION IN RECIPIENTS OF A DECEASED DONOR RENAL ALLOGRAFT AT RISK FOR DELAYED GRAFT FUNCTION — RECRUITING · PHASE2

Refine this search